ZELTIQ to Present at J.P. Morgan Healthcare Conference Print
GlobeNewswire
Monday, 06 January 2014 02:30

PLEASANTON, Calif.--ZELTIQ® (Nasdaq:ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, is scheduled to present at the

32nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco.

Event:  J.P. Morgan Healthcare Conference

Date:   January 15, 2014

Time:   3:00 p.m. PT

An audio webcast of the

Error. Page cannot be displayed. Please contact your service provider for more details. (20)

Company's presentation will be available by visiting the
investor relations section of ZELTIQ's web site at www.coolsculpting.com. A replay of the presentation will be available for 90 days.

About ZELTIQ® Aesthetics, Inc.

ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting System, is designed to selectively reduce stubborn fat that may not respond to diet or exercise. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.

CONTACT: Investor Relations:          Patrick F. Williams          ZELTIQ, Senior Vice President and CFO          925-474-2500                    Nick Laudico / Rada Milenovici          The Ruth Group          646-536-7030 / 646-536-7011          nlaudico@theruthgroup.com

ZELTIQ Aesthetics, Inc. logo




BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
  BMR:1